CDC says it has “simplified” its Covid vaccine recommendations.
In an announcement late today, the agency said that the original Covid vaccine will no longer be recommended for use in the US.
Instead, the agency recommends “that everyone ages 6 years and older receive an updated (bivalent) mRNA COVID-19 vaccine, regardless of whether they previously completed their (monovalent) primary series.”
The controversial recommendation is despite the fact that Covid vaccines can confer serious side effects, including heart issues in young people who are at near zero risk of serious illness from Covid. Additionally, experts say the vaccines have proven to have little to no effectiveness at preventing Covid or its transmission. And even if they have some effectiveness, studies show, it’s for a very limited time.
Also as part of the changes CDC announced today, “an additional updated (bivalent) vaccine dose for adults ages 65 years and older and additional doses for people who are immunocompromised…will be allowed.”
Experts say that people who are among the “fragile” elderly and immune compromised may suffer greater risk of side effects from the vaccine.
CDC and its director have publicly acknowledged that they failed at effectively managing the Covid pandemic despite trillions of tax dollars devoted to pandemic preparedness over the years, and billions more spent once Covid broke out. However, no meaningful public changes have been made at the agency, and nobody has been held responsible.
CDC says for those who do not want an “RNA” vaccine, they can still choose from another form such as Johnson’s and Johnson’s which, like some other vaccines, has been linked to the immune, paralysis-causing disorder called Guillain-Barré syndrome. Johnson and Johnson’s Covid vaccine now also comes with a warning about a dangerous and potentially deadly blood disorder called immune thrombocytopenia. To learn more about identified vaccine side effects and risks, see the links below.
Below you can read the CDC announcement.
For Immediate Release
Wednesday, April 19, 2023
CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the updated vaccine
Following FDA regulatory action, CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option of added protection from additional COVID-19 vaccine doses.
CDC’s Advisory Committee on Immunization Practices (ACIP) met today to discuss these COVID-19 vaccine recommendation changes, and the associated implications and implementation. Although there was no vote at this meeting, ACIP members expressed their support for these recommendations.
These changes include:
- CDC’s new recommendations allow an additional updated (bivalent) vaccine dose for adults ages 65 years and older and additional doses for people who are immunocompromised. This allows more flexibility for healthcare providers to administer additional doses to immunocompromised patients as needed.
- Monovalent (original) COVID-19 mRNA COVID-19 vaccines will no longer be recommended for use in the United States.
- CDC recommends that everyone ages 6 years and older receive an updated (bivalent) mRNA COVID-19 vaccine, regardless of whether they previously completed their (monovalent) primary series.
- Individuals ages 6 years and older who have already received an updated mRNA vaccine do not need to take any action unless they are 65 years or older or immunocompromised.
- For young children, multiple doses continue to be recommended and will vary by age, vaccine, and which vaccines were previously received.
Alternatives to mRNA COVID-19 vaccines remain available for people who cannot or will not receive an mRNA vaccine. CDC’s recommendations for use of (monovalent) Novavax or Johnson & Johnson’s Janssen COVID-19 vaccines were not affected by the changes made today.
CDC and ACIP will continue to monitor COVID-19 disease levels and vaccine effectiveness in the months ahead and look forward to additional discussion around potential updates this fall.
Visit The Sharyl Attkisson Store today
Unique gifts for independent thinkers
Proceeds benefit independent journalism
